Effects of chromium malate on glycometabolism, glycometabolism-related enzyme levels and lipid metabolism in type 2 diabetic rats: A dose-response and curative effects study.

J Diabetes Investig · 2015 · PMC4511299 · PMID 26221518

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

It can be observed that the FBG level of the chromium malate-treated groups showed a trend of decline in type 2 diabetic rats after the administration of chromium malate.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.